« Return to News | Awards & Advancement

SAFE-BioPharma named Computerworld Laureate

Monday, March 26, 2012 03:49 PM

SAFE-BioPharma, the global digital identity and digital signature standard for the life sciences and healthcare sectors, has been named a 2012 Computerworld Laureate.

IDG’s Computerworld Honors Program, which recognizes visionary applications of information technology promoting positive social, economic and educational change, has recognized the SAFE-BioPharma standard for its role in facilitating cloud-based collaboration between National Cancer Institute researchers and their private sector counterparts to accelerate initiation of a cancer clinical trial while lowering its costs and reducing paper-reliance. 

The public and private cancer researchers were provisioned with interoperable digital identities, a form of software installed on a computer, cell phone or other device, which establishes a close link with the user's proven identity and allows for the application of digital signatures to electronic documents. Unlike simple electronic signatures, digital signatures cryptographically guarantee the integrity of documents to which they are affixed. In the pilot study, the electronic documents were placed in the cloud, where the researchers were able to access, sign, and exchange them immediately. Prior to the study, the signature process was delayed by travel and the use of courier, fax, etc.

The 2012 Computerworld Laureates will be recognized publicly at the laureate medal ceremony and gala evening on June 4 in Washington, D.C.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.